Gri Bio Etf Alpha and Beta Analysis
| GRI Etf | USD 0.67 0.02 3.08% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as GRI Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in GRI Bio over a specified time horizon. Remember, high GRI Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to GRI Bio's market risk premium analysis include:
Beta (1.50) | Alpha 1.75 | Risk 19.06 | Sharpe Ratio 0.0902 | Expected Return 1.72 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
GRI |
GRI Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. GRI Bio market risk premium is the additional return an investor will receive from holding GRI Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GRI Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate GRI Bio's performance over market.| α | 1.75 | β | -1.5 |
GRI Bio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of GRI Bio's Buy-and-hold return. Our buy-and-hold chart shows how GRI Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.GRI Bio Market Price Analysis
Market price analysis indicators help investors to evaluate how GRI Bio etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GRI Bio shares will generate the highest return on investment. By understating and applying GRI Bio etf market price indicators, traders can identify GRI Bio position entry and exit signals to maximize returns.
GRI Bio Return and Market Media
The median price of GRI Bio for the period between Thu, Sep 5, 2024 and Wed, Dec 4, 2024 is 0.53 with a coefficient of variation of 35.21. The daily time series for the period is distributed with a sample standard deviation of 0.22, arithmetic mean of 0.62, and mean deviation of 0.18. The Etf received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | GRI Bio to Participate in a Virtual Investor CEO Connect Segment | 09/25/2024 |
2 | GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis | 10/07/2024 |
3 | GRI Bio Raises a Total of 13.9 Million in Gross Proceeds Since the Beginning of 2024 | 10/24/2024 |
4 | GRI Bio Showcases GRI-0621s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis | 11/21/2024 |
About GRI Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including GRI or other etfs. Alpha measures the amount that position in GRI Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
GRI Bio Upcoming Company Events
As portrayed in its financial statements, the presentation of GRI Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GRI Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of GRI Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of GRI Bio. Please utilize our Beneish M Score to check the likelihood of GRI Bio's management manipulating its earnings.
| 23rd of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with GRI Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.